Pharmacy Leaflets Become Focus For Patient Safety; IoM, FDA Finalize Standards

Producers of consumer medication information leaflets are hoping that FDA provides them with more time to come into compliance with standards for usefulness, even as an Institute of Medicine report is emphasizing the need for quality in the materials

More from Archive

More from Pink Sheet